| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |